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Abstract
Background: Vitamin D status and season are intrinsically linked, and both have been proposed to be associated
with glucose homeostasis in pregnancy, with conflicting results. We aimed to determine if exposure to winter and
low maternal 25 hydroxyvitamin D (25OHD) in early pregnancy were associated with maternal glucose metabolism.
Methods: This is a secondary data analysis of 334 pregnant women enrolled in the ROLO study, Dublin. Serum
25OHD, fasting glucose, insulin and insulin resistance (HOMA-IR) were measured in early (12 weeks’ gestation) and
late pregnancy (28 weeks’ gestation). Season of first antenatal visit was categorised as extended winter (November–
April) or extended summer (May–October). Multiple linear regression models, adjusted for confounders, were used
for analysis.
Results: Those who attended their first antenatal visit in extended winter had lower 25OHD compared to extended
summer (32.9 nmol/L vs. 44.1 nmol/L, P < 0.001). Compared to those who attended their first antenatal visit during
extended summer, extended winter was associated with increased HOMA-IR in early-pregnancy (46.7%) and late
pregnancy (53.7%), independent of 25OHD <30 nmol/L and confounders. Early pregnancy 25OHD <30 nmol/L and
extended winter were independently associated with significantly higher fasting glucose in late pregnancy (B = 0.15
and 0.13, respectively).
Conclusions: Women who attended their first antenatal visit during the months of extended winter were more likely to
have raised insulin resistance in early pregnancy, which had a lasting association to 28 weeks, and was independent of
25OHD. Our novel findings imply that seasonal variation in insulin resistance may not be fully explained by differences in
vitamin D status. This could reflect circannual rhythm or seasonal lifestyle behaviours, and requires further exploration.
Trial registration: ISRCTN registry, ISRCTN54392969, date of registration: 22/04/2009, retrospectively registered.
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Background
Vitamin D status and season are intrinsically linked;
upon exposure to natural ultraviolet solar radiation,
endogenous skin production of vitamin D occurs. How-
ever, in countries at northern latitudes, such as Ireland
(51–55°N), production reduces substantially from October
to March [1, 2] with striking seasonal variation observed
in 25-hydroxyvitamin D (25OHD) in pregnant and non-
pregnant populations [3–5].
The presence of vitamin D receptors and expression of
1-α-hydroxylase enzyme in pancreatic beta cells suggest
that vitamin D may be a modulator of insulin secretion
and thus, influence glucose homeostasis [6]. In preg-
nancy, the association between low vitamin D levels and
abnormalities in glucose tolerance is the subject of
scientific debate, with some studies reporting that mater-
nal insulin sensitivity, fasting glucose and gestational
diabetes are not associated with 25OHD [7], while
others have found inverse associations between 25OHD,
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fasting glucose [8] and risk of gestational diabetes [9].
However, the majority of vitamin D supplementation
intervention trials in pregnancy have not had a signifi-
cant impact on maternal and offspring health [10].
The physiological response to sunlight exposure, be-
yond that of vitamin D production, includes regulation
of biological circadian and circannual rhythms, control
of circulating melatonin, as well as production of nitric
oxide, a vasodilator, and beta-endorphins which promote
a feeling of well-being [11–13]. Circadian rhythms follow
the daily, 24-h light-dark cycle [14], while seasonal fluc-
tuations influence circannual rhythms [15]. Disruption
of our circadian clock, for example though shift work
that interferes with light-dark environmental phases, can
negatively affect cardiometabolic function and increase
insulin resistance [16]. The duration of natural sunlight
in our environment varies depending on season, and al-
though it is known that many animals adapt physiologic-
ally and behaviourally in order to survive the changing
seasons, there is also evidence of circannual biological
clocks among humans [15, 17]. Epidemiological data
suggest that seasonality in sunlight and vitamin D are re-
lated to mortality and infection rates [18]. Seasonal vari-
ation has been reported in HbA1c and glucose
concentrations among individuals with type 2 diabetes,
with highest levels observed in winter and lowest in
summer [19–23]. Two separate cohort studies recently
reported the prevalence of gestational diabetes diagnosis
to be significantly higher in summer compared to winter
[24, 25]. These findings are in keeping with another
study that found the highest incidence of gestational dia-
betes in pregnancies with winter conception [26]. How-
ever, conflicting evidence exists [27, 28]. The seasonal
differences outlined in the studies above could be attrib-
uted to seasonal 25OHD, or evolutionary circannual
rhythms to protect mother and fetus. There are also
other factors that are influenced by season: diet [29],
physical activity levels [30], and even body mass index
[31]. Due to the seasonal nature of 25OHD concentra-
tions in many parts of the world [32], and the observed
associations between vitamin D and insulin resistance, it
would seem prudent to hypothesise that seasonal vari-
ation of glucose homeostasis may be mediated through
25OHD. In 2016 the Scientific Advisory Committee on
Nutrition stated that the metabolic implications of sea-
sonal variation in serum 25OHD remain unknown,
highlighting the necessity for research on this topic [33].
We hypothesised that gestating through winter in early
pregnancy is associated with both reduced serum
25OHD and increased markers of glucose metabolism
(fasting glucose and insulin resistance); that reduced
serum 25OHD is associated with increased markers of
glucose metabolism; and that seasonal differences in
these markers are associated with seasonal variation in
serum 25OHD. Given the exploratory nature of this
work, we also planned to conduct post-hoc exploratory
analyses where appropriate.
Methods
Study design and setting
This is a secondary data analysis of 334 pregnant women
enrolled in the ROLO (Randomised cOntrol trial of a
LOw glycaemic index diet in pregnancy to prevent macro-
somia) study between 2007 and 2011 at The National
Maternity Hospital, Dublin, Ireland. Detailed methods and
results of this study have been previously published [34,
35]. In brief, 800 secundigravida women, who had previ-
ously delivered a macrosomic infant (>4000 g), were ran-
domised to receive either low glycaemic index dietary
advice or usual care (no dietary advice) [34]. Although the
primary outcome of birth weight did not significantly dif-
fer between the intervention and control group, the sec-
ondary outcomes of dietary glycaemic index, gestational
weight gain and glucose intolerance were significantly re-
duced in the intervention arm. Insulin, but not HOMA,
was significantly reduced in the intervention arm. No dif-
ference in serum 25OHD was noted between groups. The
study was conducted per the guidelines laid down in the
Declaration of Helsinki with institutional ethical approval
and written maternal consent.
Patient eligibility
Participants were recruited at the first antenatal hospital
visit. Eligible participants were 10–18 weeks’ gestation, with
a singleton pregnancy, over 18 years of age, not taking any
medication, and without previous or current gestational
diabetes. Only those who had completed the 2-year follow-
up appointment had serum 25OHD measured in the preg-
nancy sample, thus 334 participants were included.
Data collection
At the first antenatal consultation, participants were
weighed in light clothing using a SECA weighing scales
(SECA GmbH & Co. Kg. Germany) to the nearest 0.1 kg
and height was measured without shoes to the nearest
0.1 cm using a wall-mounted stadiometer. Body mass
index (BMI) (kg/m2) was calculated.
Food and beverages consumed over three consecutive
days were recorded by participants during each trimester
using 3-day food diaries. For this study, we analysed the
early-pregnancy food diaries only. Dietary data from
food diaries were analysed using NetWISP version 3.0
(Tinuviel Software, Llanfechell, Anglesey, UK). Partici-
pants also completed a questionnaire about use of diet-
ary supplements. Information about the quantity of
vitamin D within supplements was not collected. Emo-
tional well-being was examined using the 5-item World
Health Organization Well-Being Index (WHO-5) [36].
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Physical activity, smoking and educational attainment
were also self-reported.
Fasting serum blood samples were collected at the first
antenatal visit (early pregnancy) and at the 28-week gesta-
tion visit (late pregnancy) for the measurement of insulin
and 25OHD. Fasting blood glucose was measured at both
time points, and a glucose challenge test (1-h post a 50-g
glucose load) was performed at 28 weeks’ gestation.
Laboratory analysis
Serum 25OHD concentrations were determined using
the Elecsys Vitamin D Total (Roche Diagnostics GmbH,
Mannheim, Germany) automated competitive binding
protein assay [3]. The coefficients of variation (CV) for
the 25OHD assay determined at assay verification were
as follows: inter-assay CV, 8.9% at a concentration of
49.5 nmol/L and 3.7% at 103 nmol/L (intra-assay CV,
2.9% and 1.4% respectively). To ensure a high standard
of analysis for serum 25OHD concentrations, the labora-
tory participates in an external quality assurance scheme;
Vitamin D External Quality Assessment Scheme
(DEQAS). Multianalyte profiling was performed on the
Luminex Magpix system (Luminex Corporation Austin,
USA). Plasma concentrations of insulin were determined
by the Human Endocrine Panel. Maternal insulin resist-
ance was calculated using the Homeostasis Model As-
sessment (HOMA-IR) equation: [fasting serum insulin
(μU/ml) × fasting plasma glucose (mmol/l)/22.5].
Statistical analysis
Serum 25OHD concentrations in early pregnancy were
categorised according to the Institute of Medicine;
<30 nmol/L and <50 nmol/L [37]. The change in 25OHD
from early pregnancy to late pregnancy was calculated. Par-
ticipants were dichotomised into the season during which
the first antenatal visit took place; extended summer (May–
October) or extended winter (November–April).
Data were assessed for normality using the
Kolmogorov-Smirnov test and visual inspection of histo-
grams. Non-normally distributed variables were log
transformed prior to regression analysis. Maternal char-
acteristics were explored using independent t tests,
Mann-Whitney U tests and Chi-square tests. Simple lin-
ear regression was used to determine the univariate as-
sociations between metabolic markers, 25OHD, and
early-pregnancy season. Multiple linear regression
models were created using a forced-enter approach and
were adjusted for confounders. To estimate the associ-
ation between exposure to extended winter and the
transformed metabolic markers, the reverse transform-
ation of the B values from regression models were com-
puted. Percentage differences in metabolic markers were
calculated using the equation: ([eB-1]*100). We carried
out sensitivity analysis using different thresholds for
25OHD in the multiple regression models. Statistical
analyses were performed using IBM SPSS Statistics for
Windows, Version 20.0 (IBM, Armonk, NY). Results
were considered statistically significant if P < 0.05.
Results
Participant characteristics - demographics
Half of the participants attended their first antenatal visit
during extended winter (November–April) (n = 166
[49.7%]). Maternal characteristics, as described in Table 1,
Table 1 Participant Characteristics








Age (years) 33.0 (3.9) 32.8 (3.7) 33.2 (4.0) 0.409
Gestation at first antenatal visit (weeks) 12.8 (2.3) 12.7 (2.3) 12.9 (2.2) 0.556
BMI at first antenatal visit
Mean (SD), (kg/m2) 26.3 (4.5) 26.3 (4.4) 26.2 (4.7) 0.948
Underweight (BMI <18.5 kg/m2) [n (%)] 2 (0.6) 1 (0.6) 1 (0.6) 0.953
Normal (BMI 18.5–24.9 kg/m2) [n (%)] 153 (45.8) 78 (46.4) 75 (45.2)
Overweight (BMI 25.0–29.9 kg/m2) [n (%)] 125 (37.4) 60 (35.7) 65 (39.2)
Obese (BMI >30.0 kg/m2) [n (%)] 52 (15.6) 27 (16.1) 25 (15.1)
Smoking at baseline [n (%)] 7 (2.1) 4 (2.4) 3 (1.8) 0.697
Intervention group [n (%)] 171 (51.2) 84 (50.6) 87 (50.9) 0.829
Ethnicity: Caucasian [n (%)] 331 (99.1) 166 (100.0) 165 (98.2) 0.250
Achieved 3rd level education [n (%)] 177 (53.0) 87 (52.6) 90 (53.6) 0.940
Birth weight (g) 4065.9 (470.0) 4043.1 (434.4) 4088.4 (503.0) 0.382
Data are presented as mean (SD) unless otherwise stated
aComparison between winter and summer
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did not differ between those who attended their first
antenatal visit during extended winter or summer. A
comparison of the maternal characteristics between
those included (n = 334) and excluded from the
original ROLO study is included in Additional file 1:
Table S1.
Participant characteristics - 25OHD, season and markers
of glucose metabolism
Median (IQR) 25OHD concentrations were 39.2 nmol/
L (27.2 nmol/L) and 35.8 nmol/L (27.3 nmol/L) in early
and late pregnancy, respectively. In early pregnancy,
attending the first antenatal visit during extended win-
ter was associated with significantly lower 25OHD
concentrations than extended summer (32.9 nmol/L
[22.6 nmol/L] vs. 44.1 nmol/L [27.6 nmol/L],
P < 0.001). In early pregnancy, those who attended their
first antenatal visit in extended winter were significantly
more likely to be at risk of 25OHD deficiency
(<30 nmol/L) and 25OHD inadequacy (<50 nmol/L),
than those who attended their first antenatal visit in
extended summer (Table 2). The median (IQR) change
in 25OHD from early pregnancy to late pregnancy
among women attending the first antenatal visit during
extended winter was 0.60 nmol/L (22.42) and during
extended summer was −11.14 nmol/L (22.75). Mean
early pregnancy 25OHD versus month of first ante-
natal visit is displayed in Additional file 1: Fig. S1. In
early pregnancy, insulin and HOMA-IR, but not glu-
cose, were significantly higher among those who
attended their first antenatal visit in extended winter
(Table 2).
Unadjusted analysis – 25OHD, season and markers of
glucose metabolism
On unadjusted, simple linear regression, early-pregnancy
25OHD <30 nmol/L was not associated with any marker
of glucose metabolism in early or late pregnancy
(Table 3 [a]). Attendance at the first antenatal visit
during extended winter, compared to summer, was
associated with significantly higher early-pregnancy
HOMA-IR (31.1%) and insulin (30.6%), but not glucose
(Table 3 [b]).
Adjusted analysis (model 1) – 25OHD, season and
markers of glucose metabolism
Multiple linear regression models (Table 4) included
both 25OHD <30 nmol/L and extended winter as
predictors of the metabolic markers (Model 1), and
were also adjusted for confounders (Model 2). Prior
to analysis, collinearity between the two predictor var-
iables was measured using Spearman’s rho to ensure
they were independent; relatively low correlation was
observed between the variables (r = 0.24, P < 0.001).
Attendance at the first antenatal visit in extended
winter, compared to summer, was associated with sig-
nificantly higher HOMA-IR (32.8%) and insulin
(32.4%) in early pregnancy, independent of 25OHD
<30 nmol/L. Neither extended winter nor 25OHD
<30 nmol/L were associated with glucose in early or
late pregnancy, or the GCT in late pregnancy (Model
1, Table 4). An interaction term (early-pregnancy
25OHD <30 nmol/L * winter) was subsequently added
to the model, but was not significant in any model
(data not shown).
Table 2 Maternal 25OHD and markers of glucose metabolism in early and late pregnancy among the total group and categorised
by season of first antenatal visit








25OHD early <30 nmol/L a 90 (26.9) 64 (38.6) 26 (15.5) <0.001
25OHD early <50 nmol/L a 205 (61.4) 121 (72.9) 84 (50.0) 0.002
25OHD 28 weeks <30 nmol/L a 111 (33.2) 56 (33.7) 55 (32.7) 0.662
25OHD 28 weeks <50 nmol/L a 211 (63.2) 103 (62.0) 107 (63.7) 0.999
HOMA-IR early b 2.1 (2.6) 2.4 (2.8) 1.7 (2.0) 0.004
HOMA-IR 28 weeks b 2.8 (3.15) 2.9 (3.4) 2.6 (2.6) 0.064
Insulin early (μU/mL) b 11.3 (12.3) 12.8 (13.1) 9.3 (11.1) 0.002
Insulin 28 weeks (μU/mL) b 14.4 (15.6) 14.6 (16.8) 14.1 (11.8) 0.108
Fasting glucose early (mmol/L) c 4.48 (0.35) 4.47 (0.33) 4.49 (0.37) 0.566
Fasting glucose 28 weeks (mmol/L) c 4.46 (0.46) 4.49 (0.45) 4.42 (0.46) 0.157
1-h GCT 28 weeks (mmol/L) c 6.48 (1.44) 6.47 (1.39) 6.50 (1.48) 0.864
Data presented as an (%), bmedian (interquartile range), cmean (SD)
dComparison between winter and summer
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Post-hoc analysis - exploring potential confounders
Dietary intakes, lifestyle behaviours, and emotional
well-being were analysed by season of first antenatal
visit (Additional file 1: Table S2). Attendance at the
first antenatal visit during extended winter was
associated with reduced intake of energy (kcal)
(winter vs. summer; 1795.2 ± 412.0 vs.
1904.7 ± 418.2, P = 0.031), protein (g) (winter vs.
summer; 74.4 ± 17.4 vs 79.7 ± 20.7, P = 0.023) and
fat (g) (winter vs. summer; 69.9 ± 19.7 vs 77.2 ± 22.8,
P = 0.005). Physical activity and emotional well-being
scores were similar between extended winter and ex-
tended summer groups.
Adjusted analysis (model 2) – 25OHD, season and markers
of glucose metabolism
The final adjusted, multiple linear regression model in-
cluded extended winter at first antenatal visit, 25OHD
<30 nmol/L, and the following confounders: BMI (kg/m2),
education, being part of the ROLO study intervention
group, early-pregnancy energy (kcal), protein (g) and fat
(g), physical activity and well-being score (Model 2, Table
4). Compared to those who attended their first antenatal
visit during extended summer, extended winter was
associated with increased early-pregnancy HOMA-IR
(46.7%) and insulin (47.6%), independent of 25OHD
<30 nmol/L and confounders. The early-pregnancy
Table 3 Unadjusted regression analysis: Percentage difference in markers of glucose metabolism associated with, (a) Early-pregnancy
25OHD < 30 nmol/L, and (b) first antenatal visit in extended winter
(a) Early-pregnancy 25OHD <30 nmol/L (b) First antenatal visit in extended winter
Dependent Variable % Δa B 95% CI P % Δa B 95% CI P
HOMA-IR early 18.5% 0.17 (−0.04, 0.39) 0.110 31.1% 0.27 (0.08, 0.46) 0.006
HOMA-IR 28 weeks 11.6% 0.11 (−0.13, 0.39) 0.371 21.9% 0.20 (0.00, 0.40) 0.051
Insulin early (μU/mL) 16.2% 0.15 (−0.06, 0.35) 0.173 30.6% 0.27 (0.08, 0.45) 0.005
Insulin 28 weeks (μU/mL) 7.3% 0.07 (−0.16, 0.30) 0.528 19.2% 0.18 (−0.02, 0.37) 0.074
Fasting glucose early (mmol/L) 0.03 (−0.06, 0.12) 0.541 −0.02 (−0.09, 0.05) 0.566
Fasting glucose 28 weeks (mmol/L) 0.09 (−0.02, 0.21) 0.112 0.07 (−0.03, 0.17) 0.157
1-h GCT 28 weeks (mmol/L) 0.04 (−0.32, 0.41) 0.824 −0.03 (−0.34, 0.29) 0.864
a % difference in metabolic marker
Table 4 Multiple Linear Regression analysis and associated percentage difference in markers of glucose metabolism (Model 1
unadjusted, and Model 2 adjusted)
Model 1 – Unadjusted model Model 2 – Final Adjusted model
Dependent Variable Independent variable
(early pregnancy)
% Δa B 95% CI P Model P % Δa B 95% CI P Model P
HOMA-IR early Winter 32.8% 0.28 (0.08, 0.49) 0.008 0.008 46.72% 0.38 (0.15, 0.62) 0.001 <0.001
25OHD <30 nmol/L 11.6% 0.11 (−0.11, 0.32) 0.325 11.64% 0.11 (−0.14, 0.36) 0.382
HOMA-IR 28 weeks’ Winter 29.7% 0.26 (0.04, 0.49) 0.024 0.051 53.70% 0.43 (0.17, 0.69) 0.002 0.001
25OHD <30 nmol/L 4.1% 0.04 (−0.20, 0.28) 0.753 3.00% 0.03 (−0.25, 0.31) 0.837
Insulin early (μU/mL) Winter 32.4% 0.28 (0.08, 0.48) 0.007 0.010 47.57% 0.39 (0.16, 0.62) 0.001 <0.001
25OHD <30 nmol/L 8.3% 0.08 (−0.14, 0.29) 0.474 8.16% 0.08 (−0.17, 0.32) 0.530
Insulin 28 weeks (μU/mL) Winter 25.9% 0.23 (0.01, 0.46) 0.041 0.102 49.53% 0.40 (0.14, 0.66) 0.003 0.002
25OHD <30 nmol/L 1.0% 0.01 (−0.22, 0.24) 0.927 −0.17% 0.00 (−0.28, 0.28) 0.991
Fasting glucose early (mmol/L) Winter −0.02 (−0.11, 0.06) 0.583 0.713 −0.04 (−0.13, 0.06) 0.435 0.021
25OHD <30 nmol/L 0.03 (−0.06, 0.13) 0.469 0.06 (−0.04, 0.16) 0.257
Fasting glucose 28 weeks (mmol/L) Winter 0.07 (−0.04, 0.18) 0.185 0.118 0.13 (0.00, 0.26) 0.045 0.015
25OHD <30 nmol/L 0.08 (−0.04, 0.19) 0.208 0.15 (0.01, 0.29) 0.041
1-h GCT 28 weeks (mmol/L) Winter 0.04 (−0.31, 0.39) 0.806 0.946 0.02 (−0.41, 0.45) 0.930 0.688
25OHD <30 nmol/L 0.03 (−0.35, 0.41) 0.873 0.02 (−0.45, 0.50) 0.923
a % difference in metabolic marker
Model 1: model not controlled for confounders. Model 2: model controlled for BMI (kg/m2), education > secondary school, being part of the ROLO study
intervention group, early-pregnancy energy (kcal), early-pregnancy protein (g), early-pregnancy fat (g), moderate-vigorous activity, well-being score and
dietary supplements
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exposure to extended winter, compared to extended sum-
mer, was also associated with increased HOMA-IR
(53.7%) and insulin (49.5%) in late pregnancy. Early-
pregnancy 25OHD <30 nmol/L and exposure to extended
winter were independently associated with significantly
higher glucose in late pregnancy (B = 0.15, and 0.13, re-
spectively), controlling for confounders.
Sensitivity analysis
There were no significant changes in the multiple re-
gression models using different 25OHD variables as in-
dependent variables associated with markers of glucose
metabolism; early pregnancy 25OHD (continuous);
greater or less than 50 nmol/L (insufficiency), greater or
less than 39.2 nmol/L (median) (data not shown). Model
2 of the multiple linear regression analysis was addition-
ally controlled for change in 25OHD from early to late
pregnancy (Additional file 1: Table S3). An increase in
25OHD from early to late pregnancy was not associated
with markers of glucose metabolism.
Discussion
Exposure to extended winter in early pregnancy is asso-
ciated with increased insulin resistance in early and late
pregnancy, and increased fasting glucose in late preg-
nancy, independent of 25OHD status. Additionally,
those at risk of vitamin D deficiency in early pregnancy
are more likely to have increased fasting glucose in late
pregnancy, independent of season. Given that the associ-
ation between early gestation through extended winter
and insulin resistance is independent of serum 25OHD
<30 nmol/L, our novel findings imply that seasonal vari-
ation in insulin resistance may not be fully explained by
differences in vitamin D status. Furthermore, no inter-
action effect was observed between season and vitamin
D with regards to glucose homeostasis. Additionally, life-
style behaviours that may be influenced by seasonal
changes (dietary intakes, physical activity, and well-
being) did not explain the associations between exposure
to winter at the first antenatal visit and markers of glu-
cose metabolism. Although the seasonal variation ob-
served in insulin resistance may be caused by unknown
seasonal behaviours or residual confounding factors that
we have not included in this analysis, it is possible that
there is an unequivocal seasonal cause or circannual
rhythm associated with increased insulin resistance in
early pregnancy during winter months. Regardless of the
underlying cause for increased markers of glucose
metabolism, our findings suggest that during early preg-
nancy, exposure to a typical winter in the northern
hemisphere, which often includes low serum 25OHD, is
unfavourable for maternal glucose homeostasis.
Circannual rhythms and glucose homeostasis
Circannual rhythms have been researched in animals
with regards to reproduction, migration and hibernation,
and are biological survival mechanisms to allow certain
events to occur at the most favourable time in the year
[38]. Humans also evolved to adapt to environmental
daily and seasonal changes, with a central biological
clock located in the suprachiasmatic nucleus of the
hypothalamus, responsible for timing of metabolism,
physiology and behaviours [17]. During hunter-gatherer
times, summer was a season of increased daylight and
nutritional abundance that prepared our ancestors for
harsher winter conditions by depositing fat reserves dur-
ing autumn [17]. Through technological advances,
humans have access to light continuously and are no
longer dependant on the rising and setting of the sun to
regulate circannual rhythms. However, circadian clock
genes that respond to light are still part of our genome
[39]. Melatonin, a pineal hormone regulated by light ex-
posure, peaks during night after the onset of sleep, with
little production during daylight hours [13]. Melatonin
inhibits the release of insulin from pancreatic beta cells
[40, 41], although conflicting research exists with the
Nurses’ Health Study finding low melatonin associated
with increased risk of type 2 diabetes, potentially medi-
cated through increased insulin resistance [42]. It may
be hypothesised that during winter months, which are
characterised by increased darkness, women may be ex-
posed to melatonin close to morning and evening meals,
reducing their ability to deal with carbohydrate based
foods. It is also possible that the milieu of higher mela-
tonin and insulin resistance during winter in early preg-
nancy may set the scene for glucose homeostasis
throughout the remaining months of pregnancy. This
could explain why our findings of exposure to extended
winter in early pregnancy is associated with increased
HOMA and fasting glucose at 28 weeks’ gestation,
although research is needed to explain this potential
hypothesis.
The phenomenon of circannual rhythms has also been
explored in relation to gestational diabetes [24–26, 28].
Recently, Moses et al. prospectively evaluated 7369 oral
glucose tolerance tests (OGTT) over a 3-year period in
Australia [24]. The prevalence of gestational diabetes di-
agnosed on 1-h OGTT result was 45% higher in Novem-
ber (summer) and 46% lower in July (winter) than the
overall prevalence, however, diagnoses based on fasting
glucose concentrations were similar across the year. The
OGTTs were carried out at 24–28 weeks’ gestation; thus,
summer at the time of OGTT would correspond ap-
proximately with winter in early pregnancy in our popu-
lation. Similarly, in Sweden, Katsarou et al. analysed
11,538 pregnancies, and found a 51% increase in gesta-
tional diabetes diagnosed by OGTT in the months of
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June to July (summer), compared to other months [25].
Verburg et al. reported that conception during winter
was associated with a significantly higher incidence of
gestational diabetes than during summer [26]. We car-
ried out glucose challenge tests (1-h post 50 g glucose
load) for all women in our population, not OGTT as in
the above studies. Exposure to winter in early pregnancy
was not associated with glucose challenge test results,
however it was associated with increased fasting glucose
and insulin resistance at 28 weeks. Conversely, Janghor-
bani et al. did not find an association between season
and gestational diabetes incidence among 4942 British
women between 1996 and 1997 [28].
In non-pregnant adult populations, conflicting results
have been reported regarding seasonal variation HbA1c
(a measure that reflects average circulating blood glu-
cose concentrations for the previous 90 days) and glu-
cose concentrations among individuals with type 2
diabetes [19, 43]. Carney et al. observed significantly
higher HbA1c in the UK among female patients with
type 2 diabetes in the months February, March and June,
and suggested that poorer diet and reduced physical ac-
tivity associated with Christmas and Easter celebrations
may be involved [20]. Fasting glucose and HbA1c were
lowest among Greek patients with type 2 diabetes during
August and September [23]. The authors suggested that
a combination of seasonal changes to an individuals’
physical activity, diet, sunlight exposure, weather pat-
tern, psychological variables, and weight changes may be
contributing factors [23]. In our cohort, dietary energy,
protein and fat were significantly higher during extended
summer, while carbohydrates, glycaemic index, gly-
caemic load, physical activity and well-being were no dif-
ferent across seasons. During summer, early pregnancy
energy (kcal) was associated with a negligible reduction
in late pregnancy insulin resistance (−0.1%), while fat (g)
was associated with a small increase in late pregnancy
insulin resistance (1.4%). The other seasonal behaviours
were not significantly associated with metabolic markers.
Traditionally, and in may regions of the world today,
seasonal availability of food determines dietary intakes.
However, in developed countries, seasonal availablity of
food has a limited impact on diet, although seasonal dif-
ferences in dietary intakes among pregnant women have
been observed [29]. It is possible that the increased en-
ergy, protein and fat observed in our study during ex-
tended summer could be due to changes in dietary
habits during the summer holidays. Debate also exists in
relation to seasonality of physical activity levels [30, 44].
Our study did not find a difference in self-reported
physical activity across the seasons.
Whether environmentally or biologically driven, we
found novel evidence of seasonal rhythms in insulin re-
sistance. It could be hypothesised that increased insulin
resistance during winter pregnancies is an evolutionary
protective mechanism for the mother and fetus, of laying
down additional fat stores to ensure survival through
winter. Further research is required to determine the
physiological pathways and clinical significance of our
observations.
25OHD and glucose homeostasis
Within our cohort, early-pregnancy 25OHD <30 nmol/L
was associated with significantly higher fasting glucose
at 28 weeks’ gestation, independent of season and poten-
tial confounders. Low 25OHD at the first antenatal visit
was not associated with insulin resistance in early or late
pregnancy when controlling for season and confounders.
Our results are similar to those of the HAPO trial,
which found that maternal insulin sensitivity and gesta-
tional diabetes were not associated with 25OHD [7].
However, unlike the HAPO trial, we found increased
fasting plasma glucose in late pregnancy among those at
risk of vitamin D deficiency. A recent meta-analysis of
observational studies reported that vitamin
D < 50 nmol/L was associated with an increased risk
(OR = 1.53) of developing gestational diabetes [9].
Many women who gestate through a typical winter in
the northern hemisphere are at risk of vitamin D defi-
ciency [4, 5]. Poor vitamin D intakes have been reported
among pregnant women living in Ireland [5]. In the clin-
ical setting, pregnant women should receive advice
about vitamin D, especially during winter. Winter-time
supplementation of 1000 IU/day vitamin D is an effect-
ive strategy to improve 25OHD in pregnancy [45]. At
present, there remains a lack of consensus regarding rec-
ommendations for UVB exposure for the production of
vitamin D for pregnant women [46]. Our findings sug-
gest that women at risk of vitamin D deficiency in early
pregnancy have altered glucose metabolism in later ges-
tation, but the evidence is not consistent for insulin re-
sistance. Thus, recommendations for vitamin D
supplementation to improve glucose homeostasis in
pregnancy cannot be made based on our results.
Strengths and limitations
A potential limitation of our work is the dichotomised
seasonal divisions. However, we chose these for multiple
reasons; the HAPO study used similar divisions in coun-
tries with a latitude of 41.9–43.7° North [7], mean daily
temperatures in Ireland are highest during the months
May to October [47], and we based these seasons on
25OHD concentrations for the month of the first ante-
natal visit (Additional file 1: Fig. S1). Some studies have
attributed seasonal differences in gestational diabetes to
temperature changes. Although we did not collect data
on daily temperature, the temperatures in Ireland are
relatively stable across the year, with mean temperature
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of 5.3 °C in January and 15.6 °C in July [47], reducing the
likelihood that temperature is responsible. Detailed data on
micronutrient supplement use were not available, however,
use of dietary supplements (yes/no) was included as a con-
founder in multiple regression models. Data relating to pre-
pregnancy lifestyle behaviours were not collected. The gener-
alisability of our findings may be limited, as participants had
previously given birth to a macrosomic infant (>4000 g), and
half the women received advice to follow a low glycaemic
diet. We controlled for intervention grouping in the multiple
linear regression models. Furthermore, only women who
attended the 2-year follow-up appointment had pregnancy
serum 25OHD measured, and some differences were ob-
served in the baseline characteristics of those included and
excluded from this analysis [48]. Our research would be
strengthened with the addition of HbA1c data in pregnancy
and additional maternal lifestyle variables to allow the associ-
ations to be teased out. The use of GTT (75 g glucose load),
rather than glucose challenge test, would have allowed for
better comparison with the seasonal gestational diabetes pa-
pers discussed, however universal screening for gestational
diabetes using GTT is not currently standard practice in
Ireland. Additionally, our findings are observational in nature
thus we cannot determine causality.
Conclusions
Women who attend their first antenatal visit during the
months of extended winter were more likely to have raised
insulin resistance in early and late pregnancy, and in-
creased fasting glucose in late pregnancy, independent of
25OHD status. Participants at risk of vitamin D deficiency
at their first antenatal visit were likely to have increased
fasting glucose at 28 weeks’ gestation, regardless of season.
While no interaction effect was observed between season
and vitamin D with regards to glucose homeostasis, it is
well recognised that 25OHD declines in winter, and is a
modifiable factor. Our novel finding of the association be-
tween season and insulin resistance, independent of
25OHD, could reflect circannual rhythm or seasonal life-
style behaviours and requires further exploration.
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